Chris has more than 15 years of experience in driving significant market presence while balancing return on investment for leading brands such as AstraZeneca, Eli Lilly, Glaxo Smith Kline, Johnson & Johnson, Novartis and Sanofi. Chris’s detailed approach in understanding the client’s business objectives, their competitive landscape, and defining what success means to them has resulted in a track record of driving a significant return on marketing dollar spent for both professional and consumer marketing campaigns.
Prior to joining Merkle, Chris was with Epsilon where he led business development efforts within the Health vertical by developing partnerships with top pharma, biotech, insurance, and medical device companies. Chris has a degree in Business and Marketing from the University of Delaware.
